Issue of Equity

Source: RNS
RNS Number : 8704T
Gamma Communications PLC
29 March 2021
 

 

29 March 2021

Gamma Communications plc

("Gamma" or the "Company")

 

Issue of Equity

 

Further to the announcement dated 3 March 2021, certain of the vendors of Mission Labs have reinvested £2,846,186.27 in Gamma (approximately 10% of their consideration received from the sale of Mission Labs to Gamma), by way of a subscription for 182,086 ordinary shares of 0.25 pence each in the capital of the Company. Accordingly, the Company has applied for admission of these new ordinary shares to trading on AIM.  Admission is expected to take place at 8.00am on 6 April 2021.   

 

 

The Company's total issued share capital following admission will consist of 95,598,457 ordinary shares of 0.25 pence each with one voting right per share. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

Gamma Communications plc

Andrew Taylor, CEO

Andrew Belshaw, Chief Financial Officer

Malcolm Goddard, Company Secretary

 

Tel: +44 (0)333 006 5972

 

Investec Bank plc (NOMAD & Broker)

Patrick Robb / Sebastian Lawrence / Virginia Bull

 

 

 

 

Tel: +44 (0)20 7597 5970

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEDKLFLFXLBBBE